A significant decrease was observed at T2 in the CFS/ME group for IL-10 and IL-17A while at T3, IL-2 was increased in the CFS/ME group in comparison to the non-fatigued controls. This evidence concerns the gene IL10 and myalgic encephalomeyelitis/chronic fatigue syndrome.